MichaelTMilano Profile Banner
Michael Milano Profile
Michael Milano

@MichaelTMilano

Followers
422
Following
927
Media
13
Statuses
228

Husband&Dad | Radiation Oncologist @WilmotCancer @UR_Med Professor | Residency Program Director @NotreDame→@UR_Med (MD PhD)→@UChicagoRadonc→@UR_Med Tweets=mine

Rochester, NY
Joined October 2018
Don't wanna be here? Send us removal request.
@BenRichMD
Benjamin Rich
5 months
🧠 Brain Tumor physicians (Neuro Onc, Med Onc, Rad Onc, Nsgy): Help us assess IDHm glioma practice patterns by completing a 5–7 min anonymous survey. Enter to win one of two $50 Amazon gift cards. 👉 [Survey link]
1
10
15
@IJROBP
IJROBP - The Red Journal
1 year
Our new baby TEC is a Gemini, named PENTEC. https://t.co/hv0wjqBzvq
0
14
47
@MichaelTMilano
Michael Milano
3 years
@jryckman3 @JimmGrimm1 @LarryMa44302005 here is a link to the paper (w/o pay wall)
0
0
8
@MichaelTMilano
Michael Milano
3 years
@jryckman3 @JimmGrimm1 @LarryMa44302005 This complicated figure suggests that when the brachial plexus is within the target volume, more stringent dosimetric constraints are needed.
2
2
19
@MichaelTMilano
Michael Milano
3 years
@jryckman3 @JimmGrimm1 @LarryMa44302005 Risks of brachial plexopathy with lung SBRT seem much lower compared to the expected risks for when the brachial plexus is within the field (i.e. historic non-SBRT data)- and 2D/3D/IMRT for breast and head and neck cancer
1
0
5
@MichaelTMilano
Michael Milano
3 years
@jryckman3 @JimmGrimm1 @LarryMa44302005 NTCP model was based on treatment for apical lung tumors- for which brachial plexus is within dose gradient and outside of target.
0
0
2
@MichaelTMilano
Michael Milano
3 years
Our post-HyTEC NTCP modelling paper of radiation-induced brachial plexopathy is in press in the Green J ! https://t.co/SHcCQH9JaT NTCP models: ≈10% risks associated with brachial plexus Dmax of ∼32-34 Gy in 3 Fx and ∼40-43 Gy in 5 Fx. @jryckman3 @JimmGrimm1 @LarryMa44302005
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
A dose-response for risk of RIBP after SBRT is observed relative to brachial plexus Dmax. Comparisons to data from less conformal radiotherapy suggests potential dose-volume dependences of RIBP...
7
15
58
@SA_Rosenberg
Stephen Rosenberg, MD
3 years
Amazing work by Dr. Oliver who began this multi-institutional project as a resident. The largest series of primary lung carcinoid tumors tx w/ SBRT w/ excellent local control & outcomes. @MoffittRadOnc @ClevelandClinic @YaleRadOnc @MayoRadOnc @RU_RadOnc
3
23
97
@Oncoangel
Angel Montero Luis
3 years
It is critical to recognize that radionecrosis is an accepted and often unavoidable consequence of effective treatment of brain metastases #radonc
lnkd.in
This link will take you to a page that’s not on LinkedIn
0
5
17
@PDBrownOnc
PDBrown
3 years
Incredibly thoughtful editorial balancing tumor control and risks The Art of Radiation Therapy: The Necessary Risk of Radiation Necrosis for Durable Control of Brain Metastases https://t.co/CTRjAnSOp8 #roedu #brainmet #radiosurgery
Tweet card summary image
redjournal.org
One of the greatest challenges in radiation oncology is selecting the “optimal” radiation dose and weighing the benefits and risks of our choices. Higher doses generally increase both tumor control...
3
22
53
@MichaelTMilano
Michael Milano
3 years
Jack Frost arrived before Santa. Happy Holidays all !!
1
0
11
@subatomicdoc
Matthew Katz, MD 🇺🇸🟦
3 years
Novel Applications of Stereotactic Radiosurgery Beyond Oncology: Prospective Trials in Functional Radiosurgery Via @DanTrifMD @MichaelTMilano @JHGLab et al #radmed
0
5
13
@MichaelTMilano
Michael Milano
3 years
@sgsoltys @alinamihai2000 @JimmGrimm1 @BobTimmermanMD @BK_radiation @KristinRedmond2 @sueyom @ASTRO_org Two HYTEC papers offered some insight into tumor control probability and necrosis risks after SRS for brain metastases, but were never intended to suggest strict brain dosimetric constraints at the expense of tumor control. https://t.co/89S6FjEylY https://t.co/89S6FjEylY
1
6
10
@MichaelTMilano
Michael Milano
3 years
Our editorial emphasizes the need to accept risks of brain necrosis to adequately treat our patients with brain metastases with SRS. @sgsoltys @alinamihai2000 @JimmGrimm1 @BobTimmermanMD @BK_radiation @KristinRedmond2 https://t.co/at1qPmCC5q @sueyom @ASTRO_org
3
27
78
@radoncreview
radoncreview_org
3 years
#PENTEC Risk of Cerebrovascular events after cranial RT to #CircleofWillis 📌 Risk of stroke remains fairly low until significant f/u is achieved (i.e., attained age 45y). 📌 NF1 patients were not included in modeling. 🔁 #RadOncCalc ⚖️ @JonathanWaxerMD https://t.co/PQ8MESDZ08
3
10
19
@subatomicdoc
Matthew Katz, MD 🇺🇸🟦
3 years
@achoud72 @henry_amhenry Thanks so much for sharing, excited to see it published, thank you for accepting our work. And many thanks to @MichaelTMilano & Alina Mihai for collaborating! #radonc
0
1
3
@jryckman3
Jeff Ryckman
3 years
A reirradiation calculator is also available and was programmed by Jean Pierre Obeid of @StanfordRO_Res, now @ClevelandClinic Vero Beach (not on the bird). JP also built several other fantastic features in the "Tools" section.🙏 2/3 🦾🤓🎯 #RadOnc #Reirradiation #TreatSafely
1
1
18
@SimonLo21054188
Simon Lo
4 years
Executive summary of american radium society’s appropriate use criteria for the postoperative management of lower grade gliomas - Radiotherapy and Oncology
1
5
11
@S_W_R_O
SWRO
4 years
This #WeWhoCurie Wednesday, we continue introducing our new board with @misskatwinmd who will be taking over the resident side of our #Mentorship team! Dr. Nguyen brings a passion for encouraging girls to pursue careers in STEM fields! #RadOnc #WomenInSTEM
2
6
20